Form 4 · Filed Jun 11, 2026, 08:27 PM UTC
KALV/KalVista Pharmaceuticals, Inc.
Palleiko Benjamin L — CHIEF EXECUTIVE OFFICER
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
18 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | D | other | 479,989 | $0 | — | 0 |
| Jun 11, 2026 | D | other | 47,354 | — | — | 0 |
| Jun 11, 2026 | D | other | 29,611 | — | — | 0 |
| Jun 11, 2026 | D | other | 33,800 | — | — | 0 |
| Jun 11, 2026 | D | other | 71,700 | — | — | 0 |
| Jun 11, 2026 | D | other | 52,600 | — | — | 0 |
| Jun 11, 2026 | D | other | 33,750 | — | — | 0 |
| Jun 11, 2026 | D | other | 75,000 | — | — | 0 |
| Jun 11, 2026 | D | other | 85,000 | — | — | 0 |
| Jun 11, 2026 | D | other | 37,500 | — | — | 0 |
| Jun 11, 2026 | D | other | 20,000 | — | — | 0 |
| Jun 11, 2026 | D | other | 25,800 | — | — | 0 |
| Jun 11, 2026 | D | other | 40,000 | — | — | 0 |
| Jun 11, 2026 | D | other | 113,920 | — | — | 0 |
| Jun 11, 2026 | D | other | 125,001 | — | — | 0 |
| Jun 11, 2026 | D | other | 255,750 | — | — | 0 |
| Jun 11, 2026 | D | other | 92,560 | — | — | 0 |
| Jun 11, 2026 | D | other | 304,688 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001366244-26-000012